Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, On


OTCPK:BIOAQ - Post by User

Post by Matt0085on Feb 14, 2018 1:46am
351 Views
Post# 27555513

Personal Analysis to answer BIOA shareholders

Personal Analysis to answer BIOA shareholders1st Stage:
A meeting with the continued listing committee of the TSX is scheduled to be held on 
February 15, 2018 at which the Company may make submissions

2nd Stage: 
TSX will give a time frame to meet listing requirements (NYSE and NASDAQ have 3 months, i dont know about TSX) if company wishes to continue listing with TSX

3rd Stage:
company might decide to get delisted from TSX and listed into the Venture which will be better decision as it will benefit company and shareholerds both. 

Financing is fully aware of all the consequences and they have done maths based on the fact (unlike our random assumptions). If they see SP going up and belive streths of the company then why are we worrying about our couple of grands? However if we are one of those who cant wait and refresh screen every 5 mins then there is a risk as the price will be moving up and down untill listing issue shorted. My advice for those traders is dont wait for below 10cents and dont buy above 18cents (but its ur money, do what is right for you). 

The entire process might taker longer unless 15th Feb meeting brings the oucomes of listing in Venture. My speculation (and i might be wrong as well) SP will be fluctuated in beetween $0.1-$0.18 (considering the PP). Once the listing issue shorted, we should expect a NR answering our question why finacing agreed for USD$0.15, which will result how far BIOA can jump.

welcome all the correction if im wrong!
<< Previous
Bullboard Posts
Next >>